bioRxivBiochemistry
Dynamic changes in the brain protein interaction network correlates with progression of Aβ42 pathology in Drosophila
H. M. Scholes, A. Cryar, F. Kerr, D. Sutherland, L. A. Gethings, J. P. C. Vissers, J. G. Lees, C. A. Orengo, L. Partridge, K. Thalassinos
Abstract
Alzheimers disease (AD), the most prevalent form of dementia, is a progressive and devastating neurodegenerative condition for which there are no effective treatments. Understanding the molecular pathology of AD during disease progression may identify new ways to reduce neuronal damage. Here, we present a longitudinal study tracking dynamic proteomic alterations in the brains of an inducible Drosophila melanogaster model of AD expressing the Arctic mutant A{beta}42 gene. We identified 3093 proteins from flies that were induced to express A{beta}42 and age-matched healthy controls using label-free quantitative ion-mobility data independent analysis mass spectrometry. Of these, 228 proteins were significantly altered by A{beta}42 accumulation and were enriched for AD-associated processes. Network analyses further revealed that these proteins have distinct hub and bottleneck properties in the brain protein interaction network, suggesting that several may have significant effects on brain function. Our unbiased analysis provides useful insights into the key processes governing the progression of amyloid toxicity and forms a basis for further functional analyses in model organisms and translation to mammalian systems.
- organism: Drosophila
- assay: proteomics
- research focus: cell type annotation
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Amyloid accumulation drives proteome-wide alterations in mouse models of Alzheimers disease like pathology
Jeffrey N. Savas, Yizhi Wang, … John R. Yates·Cell ReportsPeer-reviewed·Nov 1, 2017
- Network analysis of mouse brain proteomes resolves molecular and cellular endophenotypes of aging and Aβ pathology
Sruti Rayaprolu, Sneha Malepati, … Srikant Rangaraju·bioRxiv·Nov 6, 2026
- Amyloid fibril proteomics of AD brains reveals modifiers of aggregation and toxicity
Arun Upadhyay, Deepak Chhangani, … Jeffrey N. Savas·Molecular NeurodegenerationPeer-reviewed·Sep 14, 2023
- Compilation of all known protein changes in the human Alzheimer's disease brain
Manor Askenazi, Tomas Kavanagh, … Eleanor Drummond·bioRxiv·Apr 13, 2023
- A proteomics analysis of 5xFAD mouse brain regions reveals the lysosome-associated protein Arl8b as a candidate biomarker for Alzheimer's disease
Annett Boeddrich, Christian Haenig, … Erich E. Wanker·Genome MedicinePeer-reviewed·Jul 19, 2023
- Diversity of Abeta aggregates produced in a gut-based Drosophila model of Alzheimer's disease
Greta Elovsson, Therése Klingstedt, … Ann‐Christin Brorsson·bioRxiv·Nov 19, 2024